Multiple Myeloma 101: Understanding Your Labs
|
|
- Augusta Parks
- 5 years ago
- Views:
Transcription
1 Multiple Myeloma 101: Understanding Your Labs Tim Wassenaar MD MS Hematologist, Director of Clinical Trials UW Cancer Center at ProHealth Care
2 None Disclosures
3 Outline Define hematopoiesis WBCs, RBCs, platelets What is multiple myeloma? How do we diagnose myeloma?
4 Outline Laboratory studies Monoclonal protein Immunoglobulins, beta 2 microglobulin Bone marrow biopsy Laboratory results in the setting of multiple myeloma CRAB Free light chains Conclusions
5 Hematopoiesis Websters defines as: the formation of blood or of blood cells in the living body. Where are blood cells made?
6 Bone Marrow Williams, 2009
7 White Blood Cells (Leukocytes) Neutrophils eat bacteria produce inflammatory molecules Lymphocytes make antibodies kill foreign or infected cells regulate immune system Plasma Cell Monocytes eat bacteria and other unwanted things regulate immune system
8 Red Blood Cells (Erythrocytes) Biconcave discs top side Little bags of hemoglobin Function: carry 0 2 to tissues, CO 2 to lungs
9 Platelets Smallest formed elements in blood Not really cells (no nuclei) but fragments of large cells called megakaryocytes found mainly in bone marrow Function: help blood clot, prevent bleeding
10 How do we diagnose multiple myeloma? Laboratory evaluation Complete blood count Protein studies (serum, urine) Serum immunoglobulins (IgG, IgM, IgA) Kidney function, chemistries, calcium, albumin Radiographic evaluation Xrays (skeletal survey) CT, MRI, PET scan also used in certain circumstances Pathologic evaluation Bone marrow biopsy
11 Laboratory Studies Monoclonal protein 97% of patients will have a protein in the blood or urine 80% of time protein is seen by SPEP Up to 93% of time if immunofixation performed 97% if serum free light chains and urine protein studies are performed No detectable monoclonal protein (3%) Non-secrectory myeloma
12 Monoclonal Protein Uptodate, 2017
13 Laboratory Studies Monoclonal protein IgG 52 percent IgA 21 percent Kappa or lambda light chain only (Bence Jones) 16 percent IgD 2 percent Biclonal 2 percent IgM 0.5 percent Negative 6.5 percent Uptodate, 2017
14 Laboratory Studies Free light chain Measures kappa and lambda immunoglobulin chains not bound to heavy chains Normal is Kappa:Lambda ratio of 2:1 Abnormal free light chain ratio seen in 90% of patients with multiple myeloma Now considered a diagnostic criteria for multiple myeloma
15 Laboratory Studies Serum Immunoglobulins Measurement of normal and abnormal protein IgG, IgM, IgA If no localized band seen on SPEP, 20% have hypogammaglobulinemia Reduction of normal uninvolved immunoglobulin levels common 91% have one, 73% have both reduced
16 Laboratory Studies Beta 2 microglobulin Serum test Prognostic factor for multiple myeloma staging Elevated in 75% of patients at diagnosis Higher level represents: Greater tumor burden Can be associated with renal failure
17 Laboratory Studies Bone Marrow biopsy Key component to diagnosis of myeloma 3 main components: Morphology # and appearance of plasma cells Immunophenotype Monoclonal, kappa/lambda ratio Cytogenetics Chromosome abnormalities of myeloma cells
18 Bone Marrow Williams, 2009
19 Bone Marrow: Cytogenetics Chromosome abnormalities play a major role in development of multiple myeloma Detected by: Karyotype (20-30% detection rate) Ploidy (Gain/trisomy, loss/hypodiploidy) Deletion/monosomy Flourescent in situ hybridization (FISH) Play a major role in prognosis
20 Bone Marrow: Cytogenetics
21 Bone Marrow Cytogenetics No abnormality better than any Detection of a clone reflects dividing cells High Risk Hypodiploidy Intermediate Risk Deletion 13 Low Risk/Favorable Hyperdiploidy
22 Bone Marrow: FISH Blood 2002;99:3735
23 Bone Marrow Cytogenetics/FISH Msmart guidelines, accessed 11/2017
24 Laboratory Studies: Clinical Presentation Calcium increased Renal dysfunction Anemia Bone lesions
25 CRAB: Hypercalcemia Increase in the level of calcium Seen in approximately 30% at diagnosis Serum calcium > 11 mg/dl (15%) Causes Bone destruction, loss of kidney function, monoclonal protein Symptoms Drowsiness, confusion, loss of appetite, nausea, constipation, excessive urination
26 CRAB: Kidney damage/failure Kidneys don t filter the blood as well Usually acute and reversible if caught early Creatinine above normal ( mg/dl) in 50%, > 2.0 mg/dl in 20% of cases at presentation Can be the presenting symptom of the disease Causes Monoclonal protein (ie cast nephropathy) Hypercalcemia Medications Symptoms Drowsiness, loss of appetite, nausea, constipation, excessive urination/ loss of urination
27 CRAB: Anemia Decrease in red blood cells, lower hemoglobin and hematocrit Hemoglobin 12 g/dl Present in 73% of patients at diagnosis (97% overall) Causes Bone marrow replacement Kidney damage Dilution in the case of a large M-protein Symptoms Fatigue, shortness of breath
28 CRAB: Bone Pain/Destruction Present 60% of the time at diagnosis Causes Plasma cell invasion of bone (plasmacytoma) Plasma cell induced bone destruction Symptoms Back or chest pain most common, but also in arms and legs Pain worse with movement, goes away with rest Can cause loss of height Spinal cord compression (weakness in arm/leg, incontinence) (5% of patients)
29 Laboratory Studies: Immune system dysfunction Increased risk of infections Causes Impaired lymphocyte function Impaired plasma cell function Hypogammaglobulinemia (too little normal protein) Other
30 Google, 2009 Laboratory Studies: Hyperviscosity Syndrome Blood becomes thick and sticky and prone to clot Proteins (typically IgM) secreted by plasma cells Symptoms Bleeding from nose/mouth, blurred vision, headache, slurred speech, confusion, and heart failure Treatment Remove proteins from blood
31 Myeloma Diagnosis Criteria Uptodate, 2017
32 Conclusions Multiple myeloma is characterized by excess immunoglobulin protein production by plasma cells with: Detection of abnormal protein in serum and urine Increased abnormal plasma cells in bone marrow > 10% plus CRAB or FLC ratio > 100, or greater than 60% Associated symptoms: Calcium elevated Renal dysfunction Anemia Bone destruction/lesions
33 Conclusions Can cause other symptoms: Immune system dysfunction Hyperviscosity Prognosis determined by genetic/molecular testing Clinical symptoms/findings and genetic studies drive treatment decisions
34 Questions
Multiple Myeloma Early Detection, Diagnosis, and Staging
Multiple Myeloma Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be
More informationHematology 101. Rachid Baz, M.D. 5/16/2014
Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More
More informationSmoldering Multiple Myeloma. A Case Study
Smoldering Multiple Myeloma A Case Study Case Presentation 53-Year-Old Male Patient presented for a routine exam No prior history of disease or family history of fhematologic disorders d or malignancies,
More informationLaboratory Examination
Todd Zimmerman, M.D. 64 year old African American male presents to establish care with PCG. Meds: Norvasc 5 mg daily PMHx: HTN x 20 years, poorly controlled SHx: No tobacco, illicit; rare EtOH ROS: Negative
More informationM-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016
+ M-Protien, what to do next? Ismail A Sharif MD, FRCPc Internal Medicine Day 22 nd April 2016 + Disclosures Advisory Boards: AMGEN, Lundbeck, NOVARTIS + Subtypes of Plasma Cell Disorders Increased Plasma
More informationForms Revision: Myeloma Changes
Sharing knowledge. Sharing hope. Forms Revision: Myeloma Changes J. Brunner, PA-C and A. Dispenzieri, MD February 2013 Disclosures Janet Brunner, PA-C I have no relevant conflicts of interest to disclose.
More informationSWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL RESPONSE ASSESSMENT MYELOMA CHAPTER 11C REVISED: SEPTEMBER 2016
MYELOMA Quantitative Markers-Myeloma Assessment Quantitative markers are biochemicals that are recorded in tests on body fluids such as serum and urine. Applicable Disease Sites The myeloma disease site
More informationMultiple myeloma Biological & Clinical Aspects Isabelle Vande Broek, MD, PhD
Multiple myeloma Biological & Clinical Aspects Isabelle Vande Broek, MD, PhD Department of Oncology & Hematology AZ Nikolaas Iridium Kanker Netwerk Introduction Multiple myeloma = Kahler s disease Dr.
More informationMultiple Myeloma: diagnosis and prognostic factors. N Meuleman May 2015
Multiple Myeloma: diagnosis and prognostic factors N Meuleman May 2015 Diagnosis Diagnostic assessment of myeloma: what should we know? Is it really a myeloma? Is there a need for treatment? What is the
More informationCase #1. Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute
Case #1 Robert J. Glinert, M.D. David C. Fisher, M.D. Dana Farber Cancer Institute Patient History Part I 76 year-old man 1997 diagnosed with MGUS (biclonal) during evaluation of (self-limited) anemia.
More informationCriteria for Disease Assessment Joan Bladé
Criteria for Disease Assessment Joan Bladé Unidad de Amiloidosis y Mieloma Servicio de Hematología Hospital Clínic de Barcelona COMy Meeting, París, May 4th, 2018 Response Evaluation EBMT, 1998 - CR and
More informationKeeping track of your numbers
Keeping track of your numbers If you have relapsed or refractory multiple myeloma, keeping track of your numbers can help you take an active role in your care. It s also one way you and your doctor can
More informationLec-14 د.خالد نافع. Medicine. Multiple Myeloma
Fifth stage Lec-14 د.خالد نافع Medicine 24/4/2016 Multiple Myeloma Plasma cell myeloma Variants Non - secretory myeloma Indolent myeloma Smouldering myeloma Plasma cell leukaemia Plasmacytoma - Solitary
More informationTracking Disease Status for Multiple Myeloma
Tracking Disease Status for Multiple Myeloma This appendix is intended to provide additional resources when determining: Best response to line of therapy pre-transplant; Disease Status at the Last Evaluation
More informationInstructions for Plasma Cell Disorders (PCD) Post-HCT Data (Form 2116 Revision 3)
(Form 2116 Revision 3) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Plasma Cell Disorders (PCD) Post-HCT Data Form. E-mail comments regarding the
More informationManagement of Multiple Myeloma
Management of Multiple Myeloma Damian J. Green, MD Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance New Treatment Options Have Improved OS in MM Kumar SK, et al. Blood. 2008;111:2516-2520.
More information2013 AAIM Pathology Workshop
2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone
More informationTESTS AND INVESTIGATIONS FOR MULTIPLE MYELOMA A guide for patients and caregivers
TESTS AND INVESTIGATIONS FOR MULTIPLE MYELOMA A guide for patients and caregivers Developed by the Myeloma Special Practice Network (M-SPN) of the Haematology Society of Australia and New Zealand (HSANZ)
More informationMyeloma Support Group: Now and the Horizon. Brian McClune, DO
Myeloma Support Group: Now and the Horizon Brian McClune, DO Disclosures Consultant to Celgene Objectives Transplant for myeloma- is there any thing new? High risk disease University protocols New therapies?
More informationSerum Free Light Chain Assay
Serum Free Light Chain Assay This Infosheet explains what light chains are, what the Serum Free Light Chain Assay is, and why it is used in AL amyloidosis. In AL amyloidosis, abnormal plasma cells in the
More informationThe ABCs of Waldenström s Macroglobulinemia (WM)
The ABCs of Waldenström s Macroglobulinemia (WM) Jeffrey V. Matous MD Colorado Blood Cancer Institute IWMF Ed Forum May 2017 Objectives Describe the roots underneath WM Review incidence, possible risk
More informationJo Abraham MD Division of Nephrology University of Utah
Jo Abraham MD Division of Nephrology University of Utah 68 year old male presented 3 weeks ago with a 3 month history of increasing fatigue He reported a 1 week history of increasing dyspnea with a productive
More informationAnaemias and other Pesky Haematology Questions
Anaemias and other Pesky Haematology Questions 3 main topics How do I work out an anaemia.. That oh too common paraprotein patient. Those mildly raised lymphocyte count GP discussed patient with me over
More informationPlasma cell myeloma (multiple myeloma)
Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells
More informationImportancia del laboratorio en el seguimiento clínico de pacientes con mieloma múltiple
Importancia del laboratorio en el seguimiento clínico de pacientes con mieloma múltiple Joan Bladé Unidad de Amiloidosis y Mieloma Servicio de Hematología Hospital Clínic de Barcelona Málaga, 16 de noviembre
More informationHaematological Cancer Suspected (Adults & Children)
Haematological Cancer Suspected (Adults & Children) Link to NICE guidelines: https://www.nice.org.uk/guidance/ng47 Patient of any age presents with symptoms of possible haematological cancer If 60 years
More informationTarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT
The Kidney in Multiple Myeloma Tarek ElBaz, MD. Prof. Internal Medicine Chief, Division of Renal Medicine Al Azhar University President, ESNT Normal Cell Plasma cells produce antibodies that bind to antigens,
More informationHematology Case Conference 8/5/03
Hematology Case Conference 8/5/03 Bone Marrow Case Patient: Emmxxx Lylexxx 74 year old AA female S/P craniotomy for SDH. Pt has Hx of HTN, DM, Crohn s disease, (R) nephrectomy. Bone marrow for abnormal
More informationBurkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8
Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology
More informationSuspecting Tumors, or Could it be cancer?
Suspecting Tumors, or Could it be cancer? Donna E. Reece, M.D. Princess Margaret Cancer Centre University Health Network Toronto, ON CANADA 07 February 2018 Background Low back pain is common However,
More information2016: Plasma Cell Disorders Pre-HCT Data
2016: Plasma Cell Disorders Pre-HCT Data Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Date of HCT for which this form is being completed: / / YYYY MM DD HCT type (check
More informationPlasma Cell Disorders (PCD) Pre-HCT Data
Plasma Cell Disorders (PCD) Pre-HCT Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: CIBMTR Recipient ID: Date of HCT for which this form is being completed: HCT type: (check
More informationMYE FORMS REVEALED RESPONSE CODES OBJECTIVES. Stringent Complete Response (scr) Complete Response (CR) I have no conflicts of interest to disclose
I have no conflicts of interest to disclose MYE FORMS REVEALED Janet Brunner, PA-C CIBMTR MKE New10_1.ppt OBJECTIVES 1) Be able to describe the criteria required for each myeloma response code 2) Be able
More informationMyelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data
Instructions for Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data (Form 2114) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Myelodysplasia/Myeloproliferative
More informationHematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD
Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Lonial S, Dimopoulos M, Palumbo A, et al. Elotuzumab therapy
More informationMultiple myeloma evolves from a clinically silent premalignant
S. VINCENT RAJKUMAR Updated Diagnostic Criteria and Staging System for Multiple Myeloma S. Vincent Rajkumar, MD OVERVIEW There has been remarkable progress made in the diagnosis and treatment of multiple
More informationIf unqualified, Complete remission is considered to be Haematological complete remission
Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous
More informationIf unqualified, Complete remission is considered to be Haematological complete remission
Scroll right to see the database codes for Disease status and Response Diagnosis it refers to Disease status or response to treatment AML ALL CML CLL MDS or MD/MPN or acute leukaemia secondary to previous
More informationBLOOD. Dr. Vedat Evren
BLOOD Dr. Vedat Evren Blood Liquid suspension of formed elements Blood = Blood cells + plasma Plasma = Coagulation factors + serum Cells = Erythrocytes + Leukocytes + Thrombocytes 8 % of the total body
More informationMajor Diagnostic Criteria
Multiple Myeloma Elizabeth Ann Coleman, PhD, RNP, AOCN Professor and Chair, Dept. of Nursing Science Cooper Chair in Oncology Nursing, College of Nursing Professor, Dept. of Internal Medicine, College
More informationCase Study. Accidental Diagnosis of Multiple Myeloma in a 44-Year-Old White Woman due to Erroneous Results via Chemical Analyzers.
Accidental Diagnosis of Multiple Myeloma in a 44-Year-Old White Woman due to Erroneous Results via Chemical Analyzers Ola Bashiti, MLS(ASCP) CM Laboratory Medicine 47:1:5-11 CLINICAL HISTORY Patient: 44-year-old
More informationUnderstanding Lab and Imaging Tests
Understanding Lab and Imaging Tests Printing of this publication made possible by an education grant from PS41 35M 6/08 Table of Contents Part 1 How to Use This Booklet 1 About the Tests 3 About Blood
More informationOverview: Blood Composition and Function
Chapter 17: Blood Overview: Blood Composition and Function Overview: Blood Composition and Function Formed elements 45% of whole blood Blood cells and cell fragments Erythrocytes Red blood cells (99.9%)
More informationWHO Classification. B-cell chronic lymphocytic leukemia/small T-cell granular lymphocytic leukemia
Blood Malignancies-II Prof. Dr. Herman Hariman, a Ph.D, SpPK (KH). Prof. Dr. Adikoesoema Aman, SpPK (KH) Dept. of Clinical Pathology, School of Medicine, University of North Sumatra WHO classification
More informationMyeloma. A guide for patients and families leukaemia.org.au
Myeloma A guide for patients and families 1800 620 420 leukaemia.org.au Contents Acknowledgments 4 Introduction 5 The Leukaemia Foundation 6 Blood cancers 10 What is myeloma? 16 Who gets myeloma? 20 How
More information1 BIO 212: ANATOMY & PHYSIOLOGY II PLATELETS. Mature Stage: No nucleus. Only 2-3 µm in diameter: significantly smaller than RBCs
1 BIO 212: ANATOMY & PHYSIOLOGY II LAB BLOOD PLATES EOSINOPHIL Contains large red-staining granules Usually 2 lobes 12-17 µm: about the size of neutrophils (2X erythrocytes) regulation/reduction of Histamine.
More informationMultiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Multiple Myeloma: A Review of 92 Cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia Salem H. Khalil, MB, BS; M. Andrew Padmos, BA(Hons), MD, FRCP(C); Peter Ernst MD, PhD;
More informationVasishta Tatapudi, M.D. October 23 rd, 2012.
Vasishta Tatapudi, M.D. October 23 rd, 2012. Case Summary Chief complaint: 45 year old African American male patient presented with left shoulder pain after minor trauma. History of present illness: Two
More informationCLL: A Guide for Patients and Caregivers CHRONIC LYMPHOCYTIC LEUKEMIA
CLL: A Guide for Patients and Caregivers LEUKEMIA LYMPHOMA CHRONIC LYMPHOCYTIC LEUKEMIA MYELOMA Introduction In the U.S. In 2006, about 91,000 people were living with CLL In 2007, more than 15,000 people
More informationBlood Cells Med Terms Quiz
Blood Cells Med Terms Quiz Question Prompt: 1 Mononuclear white blood cells (agranulocyte) formed in lymph tissue, also a phagocyte and a precursor of macrophages are leukocytes. True False Question Prompt:
More informationSpeakers Bureau/Honoraria: Celgene Pfizer
Dr. Vi Dao Speakers Bureau/Honoraria: Celgene Pfizer All honoraria was donated to CCMB Professional Association Development Fund 1. To be aware of the delegated responsibilities in the shared care model
More informationTreatment of Relapsed. A Case Study
Treatment of Relapsed Multiple Myeloma A Case Study Case Presentation Mr. V is a 61-year-old man previously diagnosed with ISS stage III IgG λ multiple myeloma with bone lesions, normal FISH and cytogenetics,
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 9: , 2015
EXPERIMENTAL AND THERAPEUTIC MEDICINE 9: 1895-1900, 2015 Clinical characteristics of a group of patients with multiple myeloma who had two different λ light chains by immunofixation electrophoresis: A
More informationUnderstanding Blood Tests
PATIENT EDUCATION patienteducation.osumc.edu Your heart pumps the blood in your body through a system of blood vessels. Blood delivers oxygen and nutrients to all parts of the body. It also carries away
More informationLaboratory diagnosis of plasma proteins and plasma enzymes
Laboratory diagnosis of plasma proteins and plasma enzymes Functions of plasma proteins Function: transport humoral immunity enzymes protease inhibitors maintenance of oncotic pressure buffering Example:
More informationWhat is the composition of blood, including blood cells? What organs and structures control the flow of blood throughout the body?
3 Chapter 10: Circulatory System and Lymphatic System In this chapter, you will learn about the structure and function of the circulatory system and lymphatic system. What is the composition of blood,
More informationBlood and Defense. Chapter 11
Blood and Defense Chapter 11 Functions of Blood 1. Carry nutrients from the small intestine and oxygen from the lung to tissues in the body 2. Transport wastes from tissues to the kidneys and carbon dioxide
More informationChapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.
Chapter 06 Lecture Outline See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes. Copyright 2016 McGraw-Hill Education. 2012 Pearson Permission Education,
More informationMichael Joffe ST6 Haematology SpR
Michael Joffe ST6 Haematology SpR Mrs SB 71 year old female on AMU Telephone referral to haematology by medicine with Hb 102 MCV 89, normal B12, Folate, Ferritin. PMH DM General decline over several weeks
More informationBlood. Biol 105 Lecture 14 Chapter 11
Blood Biol 105 Lecture 14 Chapter 11 Outline I. Overview of blood II. Functions of blood III. Composition of blood IV. Composition of plasma V. Composition of formed elements VI. Platelets VII. White blood
More informationExpanding Spectrum of Diseases Associated with Plasma Cell Dyscrasias
Expanding Spectrum of Diseases Associated with Plasma Cell Dyscrasias Eva Honsova Institute for Clinical and Experimental Medicine Prague, Czech Republic eva.honsova@ikem.cz Plasma cell dyscrasias Plasma
More information4/5/17. Blood. Blood. Outline. Blood: An Overview. Functions of Blood
Outline Blood Biol 105 Chapter 11 I. Overview of blood II. Functions of blood III. Composition of blood IV. Composition of plasma V. Composition of formed elements VI. Platelets VII. White blood cells
More informationRefractory M ultiple Multiple M yeloma Myeloma
Refractory Multiple Myeloma A Case Study Case: #1 48-Year-Old Male Presented to the ER with Fatigue and Acute Severe Lower Back Pain Patient assessment: X-ray of lumbar spine: L4 compression fracture,
More information10 Study procedures Time of clinical evaluations Required investigations. HOVON 143 MM Version 4.0, 17 MAY 2018
records should include dates, quantities, batch/serial numbers, expiration dates (if applicable), and the unique code numbers assigned to the investigational product(s) and trial patients (if applicable).
More informationAcute Lymphocytic Leukemia Early Detection, Diagnosis, and Types
Acute Lymphocytic Leukemia Early Detection, Diagnosis, and Types Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that
More informationUnderstanding the Serum Free Light Chain Assays. Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc.
Understanding the Serum Free Light Chain Assays Anne L Sherwood, PhD Director of Scientific Affairs The Binding Site, Inc. AL Amyloidosis: abnormality of proteins from Plasma Cells in the Bone Marrow Red
More informationWHICH OF THE FOLLOWING COMPRISE A
HEMATOLOGY QUESTION REVIEW WHICH OF THE FOLLOWING COMPRISE A LOGICAL SEQUENCE OF VESSELS AS BLOOD EXITS THE HEART? a. capillaries; arteries; veins b. veins; capillaries; arteries c. arteries; capillaries;
More informationThe fluid medium (blood) is a highly specialized connective tissue that consists of various blood cells (formed elements) suspended in a fluid matrix
Blood In Detail The fluid medium (blood) is a highly specialized connective tissue that consists of various blood cells (formed elements) suspended in a fluid matrix (blood plasma). The formed elements
More informationBiology 218 Human Anatomy. Adapted form Martini Human Anatomy 7th ed. Chapter 20 The Cardiovascular System: Blood
Adapted form Martini Human Anatomy 7th ed. Chapter 20 The Cardiovascular System: Blood Introduction The cardiovascular system functions as a system to transport numerous substances throughout the body
More informationHematopathology Case Study
Hematopathology Case Study AMP Outreach Course 2009 AMP Annual Meeting John Greg Howe Ph.D. Department of Laboratory Medicine Yale University School of Medicine November 19, 2009 HISTORY Case History An
More informationCase Study Discussions on the Nurse s Role in Caring for Patients With Hematologic Malignancies
Case Study Discussions on the Nurse s Role in Caring for Patients With Hematologic Malignancies Case Study Discussions on the Nurse s Role in Caring for Patients With Hematologic Malignancies Welcome and
More informationTYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA
TYPE 1 GAUCHER DISEASE PRESENTING AS PERSISTENT THROMBOCYTOPENIA, ASSOCIATED FACTOR XI DEFICIENCY & EMERGENT MYELOMA Trish Hyland, Medical Scientist, Department of Haematology, Cork University Hospital
More informationChronic Lymphocytic Leukemia (CLL)
Page 1 of 10 PATIENT EDUCATION Chronic Lymphocytic Leukemia (CLL) Introduction Chronic lymphocytic leukemia (CLL) is a type of cancer of the lymphocytes (a kind of white blood cell). It is also referred
More informationBLOOD RUNS THROUGH YOUR BODY
BLOOD RUNS THROUGH YOUR BODY WORKSHEET A Your heart and blood vessels make up your blood system. At the centre of your blood system is your heart. Its job is to pump the blood around your body. The rest
More informationBIOCHEMISTRY of BLOOD
BIOCHEMISTRY of BLOOD BCH 471 [Practical] Course Outline Title of the Experiments 1 Separation of plasma and serum from whole blood 2 Separation of main proteins in plasma and serum 3 Determination of
More informationHEMOTOLOGY. B. Helps stabilize body temperature -heats up and cools down slowly which moderates body temp
I. Body H 2 O = HEMOTOLOGY A. Variable quantities 1. sweating and urination ( ) decreases H 2 O 2. drinking H 2 O increases B. Water is found in two compartments 1. contains 2/3 of all water in your body
More informationChronic Lymphocytic Leukemia Early Detection, Diagnosis, and Staging
Chronic Lymphocytic Leukemia Early Detection, Diagnosis, and Staging Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms
More informationPLASMA CELL NEOPLASIA. Michael Miller, MD & Ajaz Shawl, MD
PLASMA CELL NEOPLASIA Michael Miller, MD & Ajaz Shawl, MD Plasma Cell Neoplasia Board Questions Case Presentation Introduction Epidemiology Presentation Diagnosis Laboratory Tests Imaging Differentials
More informationAgenda. Components of blood. Blood is Fluid Connective Tissue. Blood: General functions
Agenda Chapter 19: Blood Major functions Major Components Structure of RBCs and WBCs ABO Blood Types, and Rh Factor Lab 34.1 and Blood Typing Blood: General functions Transport of dissolved gases, nutrients,
More informationA. Blood is considered connective tissue. RBC. A. Blood volume and composition 1. Volume varies - average adult has 5 liters
A. Blood is considered connective tissue. RBC A. Blood volume and composition 1. Volume varies - average adult has 5 liters 2. 45% cells by volume called hematocrit (HCT) a. red blood cells (RBC) mostly
More informationBlood ---Ch 14. Whole blood consists of a plasma and cellular component.
Blood ---Ch 14 Circulating blood provides a vital function for survival: transports hormones to their destination, waste products to the kidneys for removal and transports ions / chemicals to various parts
More informationBlood Lecture Outline : Fluid Connective Tissue Part I of the Cardiovascular Unit
Blood Lecture Outline : Fluid Connective Tissue Part I of the Cardiovascular Unit General Characteristics: Extracellular matrix ph Volume Functions of the blood: 1. Transport 2. Regulation 3. Protection
More informationChapter 13 The Blood
Chapter 13 The Blood Copyright 2015 Wolters Kluwer Health Lippincott Williams & Wilkins Overview Key Terms agglutination erythrocyte lymphocyte albumin fibrin megakaryocyte anemia hematocrit monocyte antigen
More informationLifeblood Lab Activity
History of Blood: It is the universal symbol of horror, of death, yet it is the one thing that keeps you living. It is the blood that is coursing through your veins. But, what do you really know about
More informationLeukemia. There are different types of leukemia and several treatment options for each type.
Leukemia Introduction Leukemia is the name of a group of cancers of the blood cells. Hundreds of thousands of people worldwide are diagnosed with leukemia each year. There are different types of leukemia
More informationBlood. The only fluid tissue in the human body Classified as a connective tissue. Living cells = formed elements Non-living matrix = plasma
Blood Blood The only fluid tissue in the human body Classified as a connective tissue Living cells = formed elements Non-living matrix = plasma Blood Physical Characteristics of Blood Color range Oxygen-rich
More informationREGISTRATION FORM 1 / 2
IDENTIFICATION AND BASELINE DATA REGISTRATION FORM 1 / 2 M Patient s initials: Sequential case N : SEX : F Date of birth: Place of birth I I Centre I I Address I I Telephone number I I Actual profession
More informationMultiple myeloma. November 24, 2017 at Vientiane, Laos
Multiple myeloma November 24, 2017 at Vientiane, Laos Teeraya Puavilai, M.D. Division of Hematology, Department of Medicine Faculty of Medicine Ramathibodi, Mahidol University, Thailand Multiple myeloma
More informationV. Smoldering multiple myeloma
Hematological Oncology Hematol Oncol 2015; 33: 33 37 Published online in Wiley Online Library (wileyonlinelibrary.com).2213 Supplement Article V. Smoldering multiple myeloma María-Victoria Mateos 1 * and
More informationChapter 19(1) An Introduction to the Circulatory System and Blood
Chapter 19(1) An Introduction to the Circulatory System and Blood Circulatory System VS Cardiovascular System circulatory system = heart, blood vessels and blood cardiovascular system = heart and blood
More informationLymphoma Case Scenario 1
Lymphoma Case Scenario 1 HISTORY: A 23-year-old healthy female presented with a month-long history of persistent headache of increasing severity. She noted episodic nausea and vomiting in association with
More informationVelcade (bortezomib)
Velcade (bortezomib) Line(s) of Business: HMO; PPO; QUEST Integration Akamai Advantage Original Effective Date: 03/09/2004 Current Effective Date: 05/01/2017 POLICY A. INDICATIONS The indications below
More informationSuccessful Treatment of Immunoglobulin D Myeloma by Bortezomib and Dexamethasone Therapy
CASE REPORT Successful Treatment of Immunoglobulin D Myeloma by Bortezomib and Dexamethasone Therapy Naohiro Sekiguchi 1, Naoki Takezako 1, Akihisa Nagata 1, Miyuki Wagatsuma 2, Satoshi Noto 1, Kazuaki
More informationHematology Revision. By Dr.AboRashad . Mob
1 1- Hb A2 is consisting of: a) 3 ά chains and 2 γ chains b) 2 ά chains and 2 β chains c) 2 ά chains and 2 δ chains** d) 2 ά chains and 3 δ chains e) 3 ά chains and 2 δ chains 2- The main (most) Hb found
More informationHematology. The Study of blood
Hematology The Study of blood Average adult = 8-10 pints of blood Composition: PLASMA liquid portion of blood without cellular components Serum plasma after a blood clot is formed Cellular elements are
More informationBlood: Functions. Liquid connective tissue 3 general functions 1. Transportation. 2. Regulation. 3. Protection
Blood Elements Lecture Objectives List blood components. Classify formed elements of blood. Discuss the scientific basis of the above classification. Describe the basic structure of erythrocytes and criteria
More informationChapter 19: The Cardiovascular System: The Blood. Copyright 2009, John Wiley & Sons, Inc.
Chapter 19: The Cardiovascular System: The Blood Blood Liquid connective tissue 3 general functions 1. Transportation Gases, nutrients, hormones, waste products 2. Regulation ph, body temperature, osmotic
More informationUnit Seven Blood and Immunity
Unit Seven Blood and Immunity I. Introduction A. Definition Blood is a sticky fluid that is heavier and thicker than water. Blood is a type of, whose cells and suspended in a liquid intercellular material.
More informationMalignant myelomatous pleural effusion-is onset of effusion a new prognostic factor?
Turk J Hematol 2007; 24:180-184 Turkish Society of Hematology CASE REPORT Malignant myelomatous pleural effusion-is onset of effusion a new prognostic factor? Attili S, Ullas B, Lakshm D, Bapsy P.P, Lakshm
More information